Risk Warning: Beware of illegal fundraising in the name of 'virtual currency' and 'blockchain'. — Five departments including the Banking and Insurance Regulatory Commission
Information
Discover
Search
Login
简中
繁中
English
日本語
한국어
ภาษาไทย
Tiếng Việt
BTC
ETH
HTX
SOL
BNB
View Market

Leading Pharmaceutical Biotechnology rose more than 240% during the session and announced plans to acquire all shares of Conflux

2025-07-02 02:49

Odaily News The Hong Kong-listed company Leading Pharmaceutical Biotech (00399) saw a large increase in trading volume in the morning session today, rising by nearly 240% at one point during the session. The share price reached a high of HK$0.7 before falling back to around HK$0.34.
Previously, the company announced plans to acquire all the shares of blockchain project Conflux to expand its layout in the blockchain field. Two founding members of Conflux currently serve as its executive directors.